Application of the AI Platform iLN Based on DeepSeek in the Teaching of Lupus Nephritis
ConditionLearning
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorNanjing University
About this trial
Aim:
To evaluate the application effect of the teaching platform iLN in the teaching of lupus nephritis, aiming to provide practical experience and evidence-based support for the implementation of generative AI technology in professional medical education.
Method:
Based on the DeepSeek large language model, the investigators developed "iLN" - an interactive teaching platform for lupus nephritis. This platform integrates the latest authoritative textbooks, clinical guidelines, pathological atlases, and real clinical cases, and includes seven core modules, such as "case interaction", "knowledge teaching", and "AI question answering". The investigators conducted a randomized controlled trial (RCT) on 50 fourth-year undergraduate students from Nanjing University School of Medicine to evaluate the effectiveness of the iLN platform compared to traditional teaching methods. The teaching effect was evaluated through objective test scores and questionnaires about student satisfaction and platform usability.
Eligibility criteria
Qualifiers
As a student majoring in clinical medicine
Volunteering to participate in the study
Disqualifiers
Inability to understand, read, or communicate in Chinese
Failure to participate in any stage of the study (e.g. in-class education session, or post-test)
Requesting withdrawal from the study
Trial design
Treatments tested in this trial
- An iLN interactive teaching platform
- PPT
Treatment groups
50 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov